{"schema_version":"1","generated_at":"2026-11-06T08:05:32.490Z","data_as_of":null,"url":"https://www.findmykol.com/kol/andreas-klein","json_url":"https://www.findmykol.com/kol/andreas-klein/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"andreas-klein","name":"Andreas Klein","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Tufts University","institution_url":"https://www.findmykol.com/institution/tufts-university","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1285740969","orcid":"0000-0002-2559-8139","openalex":"A5062249687"},"summary":"Andreas Klein is an Oncology physician affiliated with Tufts University. OpenAlex indexes 108 publications with 1,733 citations (h-index 23); ClinicalTrials.gov lists 4 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":108,"cited_by_count":1733,"h_index":23,"latest_activity_year":2025,"source":"works"},"trials":{"count":4,"shown":3,"withheld":1,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT01610999","title":"Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation","phase":"PHASE1","status":"TERMINATED","role":"Overall official","sponsor":"Tufts Medical Center","source_url":"https://clinicaltrials.gov/study/NCT01610999","trial_url":"https://www.findmykol.com/trial/NCT01610999"},{"nct":"NCT01207765","title":"Zevalin for Patients With Incomplete Response to Chemo Prior to Autologous Stem Cell Transplant for Multiple Myeloma","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Tufts Medical Center","source_url":"https://clinicaltrials.gov/study/NCT01207765","trial_url":"https://www.findmykol.com/trial/NCT01207765"},{"nct":"NCT00676806","title":"A Phase II Study of Umbilical Cord Blood Transplantation","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Tufts Medical Center","source_url":"https://clinicaltrials.gov/study/NCT00676806","trial_url":"https://www.findmykol.com/trial/NCT00676806"}],"source":"trials"},"payments":{"company_count":10,"program_years":{"first":2021,"last":null},"rows_total":35,"shown":3,"withheld":32,"rows":[{"payer":"Regeneron","program_year":2025,"amount_usd":71665.05,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285740969"},{"payer":"AbbVie","program_year":2025,"amount_usd":58856.12,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285740969"},{"payer":"Novartis","program_year":2025,"amount_usd":51721.75,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285740969"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1285740969","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Dermatology","share_pct":100,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":100,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial","year":2025,"journal":"Nature Cancer","source_url":"https://doi.org/10.1038/s43018-025-00921-6","status":"verified"},{"title":"Teclistamab in relapsed/refractory systemic AL amyloidosis.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.7562","status":"verified"},{"title":"Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma","year":2023,"journal":"JAMA Cardiology","source_url":"https://doi.org/10.1001/jamacardio.2023.0303","status":"verified"},{"title":"Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma","year":2023,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2023010757","status":"verified"},{"title":"Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies","year":2023,"journal":"Trials","source_url":"https://doi.org/10.1186/s13063-022-06982-7","status":"verified"}],"source":"works"},"contact":{"address_1":"750 WASHINGTON ST","city":"Boston","state":"MA","zip":"021111526","phone":"617-636-5000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1285740969","source":"identity"},"similar":[{"name":"David Snydman","slug":"david-snydman","institution":"Tufts University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/david-snydman","json_url":"https://www.findmykol.com/kol/david-snydman/profile.json"},{"name":"Gitanjali M Singh","slug":"gitanjali-singh","institution":"Tufts University","url":"https://www.findmykol.com/kol/gitanjali-singh","json_url":"https://www.findmykol.com/kol/gitanjali-singh/profile.json"},{"name":"Jay Duker","slug":"jay-duker","institution":"Tufts University","specialty":"Uveitis and Ocular Inflammatory Disease","url":"https://www.findmykol.com/kol/jay-duker","json_url":"https://www.findmykol.com/kol/jay-duker/profile.json"},{"name":"Richard Karas","slug":"richard-karas","institution":"Tufts University","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/richard-karas","json_url":"https://www.findmykol.com/kol/richard-karas/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"payments":32,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-08-13","provider_certified":"2024-08-13","collected_at":"2026-11-05T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}